Pharmaceutical manufacturers would be prohibited from interfering with the ability of providers to receive prescription drugs if contracted with the 340B program, under a plan filed last week in Springfield.
Harvard researchers study COVID-19 genome to predict severity
Researchers from Harvard University studied the DNA of COVID-19 viruses taken from more than 8,000 patients in an attempt to